ONXX Financial Facts

Net loss: -53.17M
Selling, general and administrative: 87.51M
See Full Income Statement

Accumulated deficit: -737.91M
Cash and cash equivalents: 323.07M
See Full Balance Sheet

Onyx Pharmaceuticals Inc. (ONXX) Earnings

  |   Expand Research on ONXX
Next EPS Date N/A EPS Growth Rate N/A
Average EPS % Beat Rate +32.1% Revenue Growth Rate N/A
Average % Move 1-Wk after EPS +0.1% Normal Earnings Time After Close
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
8/8/13 Q213 -$0.40-$0.42 +$0.02$153M$151.73M N/A Details
5/7/13 Q113 -$0.19-$0.47 +$0.28$145.5M$134.36M N/A Details
11/1/12 Q312 -$0.79-$0.90 +$0.11$89.51M$80.02M N/A Details
8/1/12 Q212 -$0.68-$0.66 -$0.02$72.7M$72.07M N/A Details
2/21/13 Q412 -$0.36-$0.75 +$0.39$127.9M$113.17M N/A Details
5/2/12 Q112 -$0.68-$0.55 -$0.13$72M$69.82M N/A Details
11/2/11 Q311 -$0.31-$0.19 -$0.12$75.04M$80.38M N/A Details
2/22/12 Q411 $1.50$1.43 +$0.07$237M$213.24M N/A Details